Transcription of Intraluminal Volume Dose Alteplase for the …
{{id}} {{{paragraph}}}
Example: marketing
Intraluminal Volume Dose Alteplase for the …
Hosp Pharm 2015;50(3):202 207. 2015 Thomas Land Publishers, Inc. doi: Original Article Intraluminal Volume dose Alteplase for the Clearance of Occluded Peripherally Inserted Central Catheter Lines at a Long-Term Acute Care Hospital: Efficacy and Economic Impact Stephen P. Sapienza, PharmD,* and Darrin R. Ciaschini, RPh . Abstract Purpose: To evaluate the efficacy and economic impact of a maximum of 2 doses of Intraluminal Volume 1 mg/1 mL dose Alteplase for the clearance of occluded peripherally inserted central cath- eter (PICC) lines at a long-term acute care hospital (LTACH). Methods: Open-label, nonrandomized quasi-experimental trial taking place over a 3-month period from December 2013 to March 2014.
Hospital Pharmacy 203 Intraluminal Alteplase for Occluded PICC Lines Alteplase, also known as tissue plasminogen activator (tPA), is a fibrinolytic agent indicated for
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: